Bilateral Geographic Atrophy
Showing 1 - 25 of 3,942
Age-Related Macular Degeneration, Geographic Atrophy Trial run by the NEI (Sirolimus)
Completed
- Age-Related Macular Degeneration
- Geographic Atrophy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 14, 2021
Macular Degeneration, Age Related, Geographic Atrophy Trial in Madison (Spectralis FAF imaging, Optos imaging, Zeiss Clarus 700
Not yet recruiting
- Macular Degeneration, Age Related
- Geographic Atrophy
- Spectralis FAF imaging
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Jul 18, 2023
Geographic Atrophy and Their Patient Journey in United States
Not yet recruiting
- Geographic Atrophy
- (no location specified)
May 26, 2023
Geographic Atrophy, Age-Related Macular Degeneration, AMD Trial run by the CC (OT-551 antioxidant eye drop)
Completed
- Geographic Atrophy
- +2 more
- OT-551 antioxidant eye drop
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 6, 2020
Optical Coherence Tomography and Microperimetry Biomarker
Active, not recruiting
- Age-Related Macular Degeneration
- +2 more
- Natural history study
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Jul 19, 2023
Geographic Atrophy Trial in Bellaire, Dallas (OCU410)
Recruiting
- Geographic Atrophy
- OCU410
-
Bellaire, Texas
- +1 more
Aug 25, 2023
Geographic Atrophy Trial (BI 771716)
Not yet recruiting
- Geographic Atrophy
- BI 771716
- (no location specified)
Aug 29, 2023
Age-Related Macular Degeneration Trial run by the NEI (Sirolimus)
Completed
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 6, 2020
Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)
Not yet recruiting
- Geographic Atrophy of the Macula
- Macular Degeneration
- AVD-104
- Sham injection
-
Saint Petersburg, Florida
- +4 more
Apr 20, 2023
Geographic Atrophy Associated With Age-Related Macular
Recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 21, 2022
Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)
Recruiting
- Geographic Atrophy
- Macular Degeneration
- JNJ-81201887
- +4 more
-
Phoenix, Arizona
- +3 more
Mar 31, 2023
Age-Related Macular Degeneration Trial run by the NEI (Minocycline)
Active, not recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2022
Geographic Atrophy Trial in Cincinnati (OpRegen)
Recruiting
- Geographic Atrophy
- OpRegen
-
Cincinnati, OhioCincinnati Eye Institute
Jan 12, 2023
Geographic Atrophy Insights (i-GAIN) Natural History Study
Recruiting
- Dry Age-related Macular Degeneration
- +6 more
-
Belfast, United Kingdom
- +11 more
Mar 22, 2023
Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)
Not yet recruiting
- Age-Related Macular Degeneration
- Active Comparator CT1812
- Placebo Comparator
- (no location specified)
Jun 5, 2023
Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)
Recruiting
- Age-Related Macular Degeneration
- iPSC-derived RPE/PLGA transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)
Recruiting
- Age-related Macular Degeneration (AMD)
- Dimethyl Fumarate (TECFIDERA™)
- No active : no treatment
-
Créteil, Val De Marne, FranceCentre intercommunal de Créteil
Aug 2, 2022
Geographic Atrophy, Age-Related Macular Degeneration Trial in Barcelona (postbiotics (IGENH35.3A), vitamins (AREDS formulation
Active, not recruiting
- Geographic Atrophy
- Age-Related Macular Degeneration
- postbiotics (IGENH35.3A)
- vitamins (AREDS formulation and recommended daily dose)
-
Barcelona, SpainInstitut de la Màcula
Jun 18, 2022
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) Trial (EG-301, AREDS2 supplements)
Not yet recruiting
- Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
- EG-301
- AREDS2 supplements
- (no location specified)
Jul 27, 2022
Geographic Atrophy, Age Related Macular Degeneration, AMD Trial in Somerville (ALK-001 oral capsule, Placebo oral capsule)
Active, not recruiting
- Geographic Atrophy
- +3 more
- ALK-001 oral capsule
- Placebo oral capsule
-
Somerville, MassachusettsCoordinating Center
Feb 15, 2022
ORACLE: A Long-term Follow-up Study to Evaluate Safety and
Enrolling by invitation
- Age Related Macular Degeneration (AMD)
- GT005
-
Reno, NevadaSierra Eye Associates
Aug 9, 2022
Macular Degeneration Trial in United Kingdom, United States (BI 754132)
Terminated
- Macular Degeneration
- BI 754132
-
Beverly Hills, California
- +12 more
Aug 23, 2022